Mason W. Freeman

Mason W. Freeman

Teknisk/Vetenskaplig/F&U Direktör på CINCOR PHARMA, INC.
75 år
Health Technology
Consumer Services
Health Services

Profil

Mason W.
Freeman
is currently the Director of Translational Medicine at The General Hospital Corp.
He is also a Venture Partner at 5AM Venture Management LLC and a Professor at Harvard Medical School.
Additionally, he holds the position of Chief Medical Officer at CinCor Pharma, Inc. starting in 2022.
In his former roles, Dr. Freeman served as a Director at Envoy Therapeutics, Inc. and Mitobridge, Inc. He was also a Director at scPharmaceuticals, Inc. from 2018 to 2020 and an Independent Director at Crinetics Pharmaceuticals, Inc. from 2015 to 2019.
Prior to that, he was the Head of Translational Medicine at Novartis AG from 2005 to 2007.
Dr. Freeman completed his undergraduate studies at Harvard University and obtained a doctorate degree from the University of California.

Aktiva positioner av Mason W. Freeman

FöretagPositionStart
CINCOR PHARMA, INC. Teknisk/Vetenskaplig/F&U Direktör 2022-03-01
Företagsledare/Principal -
Företagsledare/Principal -
Privat kapitalinvesterare 2008-01-01

Tidigare kända positioner av Mason W. Freeman

FöretagPositionSlut
SCPHARMACEUTICALS INC. Direktör/Styrelseledamot 2020-12-01
CRINETICS PHARMACEUTICALS Direktör/Styrelseledamot 2019-07-01
Direktör/Styrelseledamot 2018-01-01
NOVARTIS AG Företagsledare/Principal 2007-04-01
Direktör/Styrelseledamot -
Se detaljerna i Mason W. Freemans erfarenhet

Mason W. Freemans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

66

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Health Technology

Consumer Services

Health Services

Finance

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Mason W. Freeman